Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Horizon Pharma, Inc. v. Dr. Reddy's Laboratories Inc., No. 19-1607 (Fed. Cir. Jan. 6, 2021)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 19-1607
Also Docketed
No. 19-1609, No. 19-1611, No. 19-1612, No. 19-1614 (consolidated; same document)
Decided
January 6, 2021
Judge
Hughes, J.
Document
Nonprecedential Opinion
Length
10 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Appellants Horizon Medicines LLC and Nuvo Phar- maceutical (Ireland) Designated Activity Company appeal the United State s District Court for the District of New HORIZON PHARMA, INC. v. DR. REDDY'S LABORATORIES INC. 3 Jersey’s grant of summary judgment that the claims of U.S. Patent Nos. 9,220,698 and 9,393,208 are invalid for indefi- niteness.